Culture models of human mammary epithelial cell transformation

Human pre-malignant breast diseases, particularly ductal carcinoma in situ (DCIS) already display several of the aberrant phenotypes found in primary breast cancers, including chromosomal abnormalities, telomerase activity, inactivation of the p53 gene, and overexpression of some oncogenes. Efforts...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of Mammary Gland Biology and Neoplasia 2000-10, Vol.5 (4), p.365
Hauptverfasser: Stampfer, M R, Yaswen, P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 4
container_start_page 365
container_title Journal of Mammary Gland Biology and Neoplasia
container_volume 5
creator Stampfer, M R
Yaswen, P
description Human pre-malignant breast diseases, particularly ductal carcinoma in situ (DCIS) already display several of the aberrant phenotypes found in primary breast cancers, including chromosomal abnormalities, telomerase activity, inactivation of the p53 gene, and overexpression of some oncogenes. Efforts to model early breast carcinogenesis in human cell cultures have largely involved studies of in vitro transformation of normal finite lifespan human mammary epithelial cells (HMEC) to immortality and malignancy. We present a model of HMEC immortal transformation consistent with the known in vivo data. This model includes a recently described, presumably epigenetic process, termed conversion, which occurs in cells that have overcome stringent replicative senescence and are thus able to maintain proliferation with critically short telomeres. The conversion process involves reactivation of telomerase activity, and acquisition of good uniform growth in the absence and presence of TGFbeta. We propose that overcoming the proliferative constraints set by senescence, and undergoing conversion, represent key rate-limiting steps in human breast carcinogenesis, and occur during early stage breast cancer progression.
doi_str_mv 10.1023/A:1009525827514
format Article
fullrecord <record><control><sourceid>proquest_osti_</sourceid><recordid>TN_cdi_proquest_journals_219243301</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>432856021</sourcerecordid><originalsourceid>FETCH-LOGICAL-c306t-5194e25bfba7e68db7353355722a592c1a9ce76100f64736d13050b258ecd0cb3</originalsourceid><addsrcrecordid>eNo1kD1PwzAURS0EoqUws6HAHrD97DhmQKoqvqRKLDBHjvOipEriYjsD_x6jlund4ejqnkfINaP3jHJ4WD8ySrXksuRKMnFClkwqyBUFfZoyLSEHytmCXISwowktC3lOFkxoBVDyJXnazEOcPWaja3AImWuzbh7NlI1mHI3_yXDfxw6H3gyZxWHIojdTaJ0fTezddEnOWjMEvDreFfl6ef7cvOXbj9f3zXqbW6BFzCXTArms29ooLMqmViABpFScG6m5ZUZbVEVyaQuhoGgYUEnrpIW2obaGFbk99LoQ-yrYPqLtrJsmtLEqQYgSEnN3YPbefc8YYrVzs5_SrIozzQUAZQm6OUJzPWJT7X3_p1n9fwR-ARABYN4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>219243301</pqid></control><display><type>article</type><title>Culture models of human mammary epithelial cell transformation</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Stampfer, M R ; Yaswen, P</creator><creatorcontrib>Stampfer, M R ; Yaswen, P ; Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)</creatorcontrib><description>Human pre-malignant breast diseases, particularly ductal carcinoma in situ (DCIS) already display several of the aberrant phenotypes found in primary breast cancers, including chromosomal abnormalities, telomerase activity, inactivation of the p53 gene, and overexpression of some oncogenes. Efforts to model early breast carcinogenesis in human cell cultures have largely involved studies of in vitro transformation of normal finite lifespan human mammary epithelial cells (HMEC) to immortality and malignancy. We present a model of HMEC immortal transformation consistent with the known in vivo data. This model includes a recently described, presumably epigenetic process, termed conversion, which occurs in cells that have overcome stringent replicative senescence and are thus able to maintain proliferation with critically short telomeres. The conversion process involves reactivation of telomerase activity, and acquisition of good uniform growth in the absence and presence of TGFbeta. We propose that overcoming the proliferative constraints set by senescence, and undergoing conversion, represent key rate-limiting steps in human breast carcinogenesis, and occur during early stage breast cancer progression.</description><identifier>ISSN: 1083-3021</identifier><identifier>EISSN: 1573-7039</identifier><identifier>DOI: 10.1023/A:1009525827514</identifier><identifier>PMID: 14973382</identifier><language>eng</language><publisher>United States: Springer Nature B.V</publisher><subject>ANIMAL CELLS ; BASIC BIOLOGICAL SCIENCES ; Breast Neoplasms - genetics ; Breast Neoplasms - pathology ; CARCINOGENESIS ; CARCINOMAS ; Cell Transformation, Neoplastic ; CELL TRANSFORMATIONS ; Cells, Cultured ; Cellular Senescence ; Disease Models, Animal ; DISEASES ; DNA-Binding Proteins ; Epithelial Cells - cytology ; GENES ; Humans ; IMMORTALITY SENESCENCE CONVERSION TELOMERASE TGFB ; IN VITRO ; IN VIVO ; INACTIVATION ; MAMMARY GLANDS ; Mammary Glands, Human - cytology ; Models, Biological ; NEOPLASMS ; NUCLEAR DISARMAMENT, SAFEGUARDS, AND PHYSICAL PROTECTION ; ONCOGENES ; Phenotype ; PROLIFERATION ; Telomerase - metabolism ; TELOMERES ; Time Factors ; TRANSFORMATIONS ; Transforming Growth Factor beta - metabolism ; Tumor Suppressor Protein p53 - physiology</subject><ispartof>Journal of Mammary Gland Biology and Neoplasia, 2000-10, Vol.5 (4), p.365</ispartof><rights>Copyright Kluwer Academic Publishers Oct 2000</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c306t-5194e25bfba7e68db7353355722a592c1a9ce76100f64736d13050b258ecd0cb3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14973382$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/834483$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Stampfer, M R</creatorcontrib><creatorcontrib>Yaswen, P</creatorcontrib><creatorcontrib>Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)</creatorcontrib><title>Culture models of human mammary epithelial cell transformation</title><title>Journal of Mammary Gland Biology and Neoplasia</title><addtitle>J Mammary Gland Biol Neoplasia</addtitle><description>Human pre-malignant breast diseases, particularly ductal carcinoma in situ (DCIS) already display several of the aberrant phenotypes found in primary breast cancers, including chromosomal abnormalities, telomerase activity, inactivation of the p53 gene, and overexpression of some oncogenes. Efforts to model early breast carcinogenesis in human cell cultures have largely involved studies of in vitro transformation of normal finite lifespan human mammary epithelial cells (HMEC) to immortality and malignancy. We present a model of HMEC immortal transformation consistent with the known in vivo data. This model includes a recently described, presumably epigenetic process, termed conversion, which occurs in cells that have overcome stringent replicative senescence and are thus able to maintain proliferation with critically short telomeres. The conversion process involves reactivation of telomerase activity, and acquisition of good uniform growth in the absence and presence of TGFbeta. We propose that overcoming the proliferative constraints set by senescence, and undergoing conversion, represent key rate-limiting steps in human breast carcinogenesis, and occur during early stage breast cancer progression.</description><subject>ANIMAL CELLS</subject><subject>BASIC BIOLOGICAL SCIENCES</subject><subject>Breast Neoplasms - genetics</subject><subject>Breast Neoplasms - pathology</subject><subject>CARCINOGENESIS</subject><subject>CARCINOMAS</subject><subject>Cell Transformation, Neoplastic</subject><subject>CELL TRANSFORMATIONS</subject><subject>Cells, Cultured</subject><subject>Cellular Senescence</subject><subject>Disease Models, Animal</subject><subject>DISEASES</subject><subject>DNA-Binding Proteins</subject><subject>Epithelial Cells - cytology</subject><subject>GENES</subject><subject>Humans</subject><subject>IMMORTALITY SENESCENCE CONVERSION TELOMERASE TGFB</subject><subject>IN VITRO</subject><subject>IN VIVO</subject><subject>INACTIVATION</subject><subject>MAMMARY GLANDS</subject><subject>Mammary Glands, Human - cytology</subject><subject>Models, Biological</subject><subject>NEOPLASMS</subject><subject>NUCLEAR DISARMAMENT, SAFEGUARDS, AND PHYSICAL PROTECTION</subject><subject>ONCOGENES</subject><subject>Phenotype</subject><subject>PROLIFERATION</subject><subject>Telomerase - metabolism</subject><subject>TELOMERES</subject><subject>Time Factors</subject><subject>TRANSFORMATIONS</subject><subject>Transforming Growth Factor beta - metabolism</subject><subject>Tumor Suppressor Protein p53 - physiology</subject><issn>1083-3021</issn><issn>1573-7039</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNo1kD1PwzAURS0EoqUws6HAHrD97DhmQKoqvqRKLDBHjvOipEriYjsD_x6jlund4ejqnkfINaP3jHJ4WD8ySrXksuRKMnFClkwqyBUFfZoyLSEHytmCXISwowktC3lOFkxoBVDyJXnazEOcPWaja3AImWuzbh7NlI1mHI3_yXDfxw6H3gyZxWHIojdTaJ0fTezddEnOWjMEvDreFfl6ef7cvOXbj9f3zXqbW6BFzCXTArms29ooLMqmViABpFScG6m5ZUZbVEVyaQuhoGgYUEnrpIW2obaGFbk99LoQ-yrYPqLtrJsmtLEqQYgSEnN3YPbefc8YYrVzs5_SrIozzQUAZQm6OUJzPWJT7X3_p1n9fwR-ARABYN4</recordid><startdate>20001001</startdate><enddate>20001001</enddate><creator>Stampfer, M R</creator><creator>Yaswen, P</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>OTOTI</scope></search><sort><creationdate>20001001</creationdate><title>Culture models of human mammary epithelial cell transformation</title><author>Stampfer, M R ; Yaswen, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c306t-5194e25bfba7e68db7353355722a592c1a9ce76100f64736d13050b258ecd0cb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>ANIMAL CELLS</topic><topic>BASIC BIOLOGICAL SCIENCES</topic><topic>Breast Neoplasms - genetics</topic><topic>Breast Neoplasms - pathology</topic><topic>CARCINOGENESIS</topic><topic>CARCINOMAS</topic><topic>Cell Transformation, Neoplastic</topic><topic>CELL TRANSFORMATIONS</topic><topic>Cells, Cultured</topic><topic>Cellular Senescence</topic><topic>Disease Models, Animal</topic><topic>DISEASES</topic><topic>DNA-Binding Proteins</topic><topic>Epithelial Cells - cytology</topic><topic>GENES</topic><topic>Humans</topic><topic>IMMORTALITY SENESCENCE CONVERSION TELOMERASE TGFB</topic><topic>IN VITRO</topic><topic>IN VIVO</topic><topic>INACTIVATION</topic><topic>MAMMARY GLANDS</topic><topic>Mammary Glands, Human - cytology</topic><topic>Models, Biological</topic><topic>NEOPLASMS</topic><topic>NUCLEAR DISARMAMENT, SAFEGUARDS, AND PHYSICAL PROTECTION</topic><topic>ONCOGENES</topic><topic>Phenotype</topic><topic>PROLIFERATION</topic><topic>Telomerase - metabolism</topic><topic>TELOMERES</topic><topic>Time Factors</topic><topic>TRANSFORMATIONS</topic><topic>Transforming Growth Factor beta - metabolism</topic><topic>Tumor Suppressor Protein p53 - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stampfer, M R</creatorcontrib><creatorcontrib>Yaswen, P</creatorcontrib><creatorcontrib>Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>OSTI.GOV</collection><jtitle>Journal of Mammary Gland Biology and Neoplasia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stampfer, M R</au><au>Yaswen, P</au><aucorp>Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Culture models of human mammary epithelial cell transformation</atitle><jtitle>Journal of Mammary Gland Biology and Neoplasia</jtitle><addtitle>J Mammary Gland Biol Neoplasia</addtitle><date>2000-10-01</date><risdate>2000</risdate><volume>5</volume><issue>4</issue><spage>365</spage><pages>365-</pages><issn>1083-3021</issn><eissn>1573-7039</eissn><abstract>Human pre-malignant breast diseases, particularly ductal carcinoma in situ (DCIS) already display several of the aberrant phenotypes found in primary breast cancers, including chromosomal abnormalities, telomerase activity, inactivation of the p53 gene, and overexpression of some oncogenes. Efforts to model early breast carcinogenesis in human cell cultures have largely involved studies of in vitro transformation of normal finite lifespan human mammary epithelial cells (HMEC) to immortality and malignancy. We present a model of HMEC immortal transformation consistent with the known in vivo data. This model includes a recently described, presumably epigenetic process, termed conversion, which occurs in cells that have overcome stringent replicative senescence and are thus able to maintain proliferation with critically short telomeres. The conversion process involves reactivation of telomerase activity, and acquisition of good uniform growth in the absence and presence of TGFbeta. We propose that overcoming the proliferative constraints set by senescence, and undergoing conversion, represent key rate-limiting steps in human breast carcinogenesis, and occur during early stage breast cancer progression.</abstract><cop>United States</cop><pub>Springer Nature B.V</pub><pmid>14973382</pmid><doi>10.1023/A:1009525827514</doi></addata></record>
fulltext fulltext
identifier ISSN: 1083-3021
ispartof Journal of Mammary Gland Biology and Neoplasia, 2000-10, Vol.5 (4), p.365
issn 1083-3021
1573-7039
language eng
recordid cdi_proquest_journals_219243301
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects ANIMAL CELLS
BASIC BIOLOGICAL SCIENCES
Breast Neoplasms - genetics
Breast Neoplasms - pathology
CARCINOGENESIS
CARCINOMAS
Cell Transformation, Neoplastic
CELL TRANSFORMATIONS
Cells, Cultured
Cellular Senescence
Disease Models, Animal
DISEASES
DNA-Binding Proteins
Epithelial Cells - cytology
GENES
Humans
IMMORTALITY SENESCENCE CONVERSION TELOMERASE TGFB
IN VITRO
IN VIVO
INACTIVATION
MAMMARY GLANDS
Mammary Glands, Human - cytology
Models, Biological
NEOPLASMS
NUCLEAR DISARMAMENT, SAFEGUARDS, AND PHYSICAL PROTECTION
ONCOGENES
Phenotype
PROLIFERATION
Telomerase - metabolism
TELOMERES
Time Factors
TRANSFORMATIONS
Transforming Growth Factor beta - metabolism
Tumor Suppressor Protein p53 - physiology
title Culture models of human mammary epithelial cell transformation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T23%3A12%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_osti_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Culture%20models%20of%20human%20mammary%20epithelial%20cell%20transformation&rft.jtitle=Journal%20of%20Mammary%20Gland%20Biology%20and%20Neoplasia&rft.au=Stampfer,%20M%20R&rft.aucorp=Lawrence%20Berkeley%20National%20Lab.%20(LBNL),%20Berkeley,%20CA%20(United%20States)&rft.date=2000-10-01&rft.volume=5&rft.issue=4&rft.spage=365&rft.pages=365-&rft.issn=1083-3021&rft.eissn=1573-7039&rft_id=info:doi/10.1023/A:1009525827514&rft_dat=%3Cproquest_osti_%3E432856021%3C/proquest_osti_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=219243301&rft_id=info:pmid/14973382&rfr_iscdi=true